[Primary cutaneous peripheral T-cell lymphoma (not otherwise specified)]

Area of Science:

• Dermatology
• Oncology
• Pathology

Background:

• Primary cutaneous peripheral T-cell lymphoma--not otherwise specified (PCTL-NOS) is a rare and heterogeneous group of skin cancers.
• These lymphomas are characterized by rapid progression and lack typical mycosis fungoides plaques.
• Limited therapeutic options and a poor prognosis are characteristic of PCTL-NOS.

Observation:

• A 62-year-old patient presented with asymptomatic papules in the popliteal and antecubital fossae.
• Histopathological examination confirmed the diagnosis of PCTL-NOS.
• The patient's presentation deviated from typical mycosis fungoides presentations.

Findings:

• The diagnosis of PCTL-NOS was established based on histopathological criteria.
• The patient's condition exhibited rapid progression.
• Morphological and molecular variability contribute to the classification challenges of PCTL-NOS.

Implications:

• Recent gene expression studies suggest potential therapeutic targets for PCTL-NOS.
• Tyrosine kinase inhibitors and histone deacetylase inhibitors may offer new treatment avenues.
• Further research into targeted therapies is crucial for improving outcomes in PCTL-NOS patients.